MM+M Podcast 2.8.23: Eisai’s pricing transparency, GAO’s report on ‘gain-of-function’ research and MrBeast’s polarizing video

Marc Iskowitz comments on Eisai's pricing transparency, Lecia Bushak discusses efforts to strengthen "gain-of-function" oversight, and Jack O'Brien addresses the recent controversy around a MrBeast video.

MM+M Staff

February 8, 2023

2:30 pm

Jack O’Brien gets Eversana CDO Scott Snyder’s JPM observations on digital health. Marc Iskowitz comments on Eisai’s pricing transparency. And Lecia Bushak discusses efforts to strengthen oversight of “gain-of-function” research. We close with the recent controversy surrounding a MrBeast video.

From Our Partners

How AI and first-party data is transforming pharma customer engagement

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

The importance of female representation in health

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.